Study Details The phase II study included 45 patients (most with follicular lymphoma) with indolent non-Hodgkin lymphoma, including 30 previously treated (28 evaluable for response) and 15 previously untreated (13 evaluable). Patients received the so-called “R-squared” regimen of ...
Caroline Helwick
Dr Maddocks, I think there is 1 subtype situation where I would argue that we should probably not give just R-CHOP, in a patient who actually has double-hit or maybe double-expression lymphoma. Do you want to comment what your experience is in this and recommendation? Kami Maddocks, MD:I...
Cycle 1b review to investigate the security as well as tolerability associated with idelalisib throughout Japanese patients using relapsed/refractory follicular lymphoma as well as long-term lymphocytic leukemia. Posted on March 19, 2025 In patients exhibiting ACA-positive status, a reduction in B-...
Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma N. Engl. J. Med, 328 (1993), pp. 1002-1006 View in ScopusGoogle Scholar Frecha et al., 2011 C. Frecha, F. Fusil, F.L. Cosset, E. Verhoeyen In vivo gene delivery...